Annual report pursuant to section 13 and 15(d)

Consolidated Balance Sheets

v2.4.0.8
Consolidated Balance Sheets (USD $)
Dec. 31, 2013
Dec. 31, 2012
Current assets:    
Cash $ 3,610,262 $ 2,354,169
Accounts receivable - net 270,000   
Marketable securities - available for sale securities 6,250 12,500
Prepaid expenses and other current assets 752,931 40,333
Assets of discontinued operations - current portion    82,145
Total current assets 4,639,443 2,489,147
Other assets:    
Property and equipment, net 13,640   
Intangible assets, net 6,157,659 492,152
Goodwill 2,144,488   
Assets of discontinued operations - long term portion    1,035,570
Total other assets 8,315,787 1,527,722
Total Assets 12,955,230 4,016,869
Current liabilities:    
Accounts payable and accrued expenses 754,945 57,158
Liabilities of discontinued operations 30,664 30,664
Total liabilities 785,609 87,822
Stockholders' Equity:    
Preferred stock, $.0001 par value, 50,000,000 shares authorized: none issued and outstanding      
Common stock, ($.0001 par value; 200,000,000 shares authorized; 5,489,593 and 3,503,565 issued and outstanding at December 31, 2013 and December 31, 2012 549 352
Additional paid-in capital 22,673,287 10,976,325
Accumulated other comprehensive income - marketable securities available for sale (6,250)   
Accumulated deficits (10,487,469) (7,037,134)
Total Marathon Patent Group, Inc. equity 12,180,117 3,939,543
Non-controlling interest in subsidiary (10,496) (10,496)
Total stockholders' equity 12,169,621 3,929,047
Total liabilities and stockholders' equity $ 12,955,230 $ 4,016,869